Biologic treatment has made a significant impact in orthopedic surgery, incorporating patient’s own cells, tissues, proteins produced artificially, etc. in the orthopedic treatment. The demand for global orthobiologics market is increasing due to the rise in aging population, changing lifestyles, problems associated with musculoskeletal system and developments in technologies. The global orthobiologics market is anticipated to grow with double digit growth rate over the forecast period with the demand for modern, safer and effective orthopedic biologic treatment. The strong growth of global orthobiologics market is predominantly driven by increasing cases of arthritis and obesity. In global orthobiologics market, the procedure of bone graft is largest segment.
Orthobiologics Market: Drivers & Restraints
The increasing innovations in technologies, aging population, presence of large number of unidentified and chronic diseases, increase in life expectancy and government initiatives are some of the drivers for the growth of global orthobiologics market. The musculoskeletal related issues especially implants have increased the demand for global orthobiologics market. The laidback lifestyle of the people, increasing rates of obesity and urbanization are driving global orthobiologics market. The technological advancement in developing pharmaceutical alternatives, of making medical treatment more of preventive rather than curative and nations’ policy for reducing the deficit in budget are some of the hindrance factors for the growth of global orthobiologics market.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-786
Orthobiologics Market: Segmentation
On the basis of application, global orthobiologics market can be segmented into:
- Spinal surgery
- Joint replacement and reconstruction
- Trauma surgery
On the basis of product, global orthobiologics market can be segmented into:
- Bone Graft Substitutes
- Demoralized Bone Matrix (DBM)
- Bone Morphogenic Proteins (BMP)
- Bone Allografts
- Bone Autographs
- Bone Growth Stimulators
- Single Injection Viscosupplementation
- 3-Injection Viscosupplementation
- 5-Injection Viscosupplementation
Orthobiologics Market: Region-wise Outlook
Global orthobiologics market is foreseen to witness the highest growth in U.S.as the region is expected to have the highest growth rate of aging population, increase in life expectancy as well as rising incidences of geriatric-based diseases. Huge number of untapped patient population, medical tourism and economical cost are driving the growth of global orthobiologics market in the emerging nations such as India and China.
Orthobiologics Market: Key Players
Some of the key players for the global orthobiologics market are: Medtronic, Genzyme, DePuy, Stryker, Zimmer, Biomet, Smith & Nephew, Synthes, K2M and Wright medical technology, Inc.
Full Report Analysis@ http://www.futuremarketinsights.com/reports/orthobiologics-market